Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer
Clinical trial NCT04523662 · UNKNOWN
Trial details
- NCT number
- NCT04523662
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-30
- Primary completion
- 2022-08-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.